EarliTec Diagnostics

EarliTec Diagnostics is a digital health company providing early diagnosis and treatment services for ASD and related disabilities to children around the world. Developed by leading researchers from Children's Healthcare of Atlanta, Emory University School of Medicine, and Yale University, EarliTec pioneered the development of biomarkers to help parents, providers, and caregivers understand how children perceive the world. The company’s initial product, EarliPoint® Autism Spectrum Disorder Assessment, has received FDA Breakthrough Device Designation as it seeks to become the first objective, clinically validated measure of individual ASD status and severity in children as young as 16 months old.